Exclusive

Publication

Byline

Location

Delhi HC orders halt to 'Olymviq' promotion as Novo accuses Dr Reddy's of breach

New Delhi, April 28 -- The Delhi High Court on Tuesday ordered Dr. Reddy's Laboratories to give an undertaking that it will not communicate or promote its generic semaglutide drug under the brand name... Read More


Dr. Reddy's can supply leftover Olymviq stock to government hospitals after 30-day window

New Delhi, March 30 -- The Delhi High Court has allowed Dr. Reddy's Laboratories to supply any remaining stock of its semaglutide drug Olymviq to government hospitals after the expiry of a 30-day stoc... Read More


Delhi HC refuses to direct Dr Reddy's to junk 'Olymviq' stock

New Delhi, March 27 -- New Delhi, Mumbai : The Delhi High Court on Friday refused to allow the destruction of Dr Reddy's Laboratories Ltd's inventory of its generic semaglutide drug, Olymviq, while ... Read More


What does the SC verdict allowing passive euthanasia mean for India?

New Delhi, March 11 -- The Supreme Court on Wednesday allowed India's first court-approved "passive euthanasia", permitting the withdrawal of life-sustaining treatment for Harish Rana, a 32-year-old m... Read More


Boost for generics as Delhi High Court says expired patents can still be cancelled

New Delhi, Feb. 25 -- India's generic drugmakers will no longer automatically face damages claims linked to expired patents after the Delhi High Court ruled that even a patent that has completed its 2... Read More


Piramal Pharma moves SC against Gujarat pollution body's plant closure order

New Delhi, Feb. 8 -- Piramal Pharma Ltd has moved the Supreme Court against a Gujarat Pollution Control Board order directing the immediate closure of its Dahej manufacturing unit over alleged environ... Read More